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Abstract: Infantile nystagmus (IN), previously known as congenital nystagmus, is an involuntary 
to-and-fro movement of the eyes that persists throughout life. IN is one of three types of early-onset 
nystagmus that begin in infancy, alongside fusion maldevelopment nystagmus syndrome  and 
spasmus nutans syndrome. Optometrists may also encounter patients with acquired nystagmus. 
The features of IN overlap largely with those of fusion maldevelopment nystagmus syndrome, 
spasmus nutans syndrome, and acquired nystagmus, yet the management for each subtype is dif-
ferent. Therefore, the optometrist’s role is to accurately discern IN from other forms of nystagmus 
and to manage accordingly. As IN is a lifelong condition, its presence not only affects the visual 
function of the individual but also their quality of life, both socially and psychologically. In this 
report, we focus on the approaches that involve optometrists in the investigation and management of 
patients with IN. Management includes the prescription of optical treatments, low-vision rehabilita-
tion, and other interventions such as encouraging the use of the null zone and referral to support 
groups. Other treatments available via ophthalmologists are also briefly discussed in the article.
Keywords: eye movements, visual acuity, reading performance, low vision, null zone, opto-
metric investigation
Introduction
Infantile nystagmus (IN), a constant involuntary to-and-fro movement of the eyes that 
persists throughout life, is one of three types of early-onset nystagmus that begin in 
infancy. Fusion maldevelopment nystagmus syndrome (FMNS), which was formerly 
known as latent nystagmus, and spasmus nutans syndrome (SNS) are the other two 
types. Previously, various terms have been used to refer to IN, the most common being 
congenital nystagmus. Despite this label, the condition is rarely present at birth. A 
study by Reinecke et al1 reported the development of nystagmus in the first 2 weeks 
of life in only three of 35 infants examined. Since IN typically develops within the 
first few months after birth, the term congenital has been replaced with infantile.2 The 
occurrence of IN in the general population is estimated to be 0.14%.3 This included 
nystagmus associated with visually impaired conditions and nystagmus with no known 
condition (idiopathic). The prevalence of any form of nystagmus (ie, not just IN) is 
estimated at 0.17% in people under the age of 18. In contrast, the prevalence is much 
higher in the adult population (0.27%).3 This increase is accounted for by cases of 
acquired nystagmus, which generally (but not always) occurs later in life. IN can occur 
spontaneously, or it may be inherited. Hereditary IN may be X-linked, recessive, or 
dominant.4 A number of genetic studies have discovered mutations in the FRMD7 gene 
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in individuals with X-linked idiopathic IN.5 These mutations 
account for approximately 20%–57% of X-linked cases of 
idiopathic IN and 3.6%–7% of isolated cases.6,7
Clinical characteristics of IN
In IN, the eyes oscillate constantly and predominantly in the 
horizontal axis, although vertical and/or torsional movement 
may be present as a secondary component.8 The nystagmus 
occurs in both eyes and is usually conjugate. Thus, the ampli-
tude of IN is similar in both eyes, ranging between 0.3° and 
15.7°, with an average frequency of 2–3 Hz.8,9 A nystagmus 
cycle consists of two phases: an initiating slow phase in 
which the eyes slowly move away from the fixation point, 
and a corrective phase where the eye moves back toward the 
fixation point (Figure 1). This corrective phase can be either 
a slow or a fast eye movement. A pendular pattern is seen 
when both the initiating and corrective phases are slow move-
ments, and a jerk pattern is seen when the corrective phase 
is a saccade. These patterns differ between individuals with 
IN, and also within the individuals themselves at different 
gaze angles or times.10
The IN waveform
The nystagmus waveform represents the position of the 
eye over time, and it is obtained by performing eye move-
ment recordings. It is described in terms of its amplitude, 
frequency, and the overall pattern or shape of the oscilla-
tion. Nystagmus intensity is calculated by multiplying the 
nystagmus amplitude by the frequency, thus representing the 
average velocity of the eye movements.11 The intensity of an 
individual’s nystagmus is not typically constant and can be 
influenced by a number of factors. Among these factors is 
the direction of gaze. The intensity of IN is at a minimum at 
certain gaze angle(s) known as the null zone. The null zone 
is within 10° of the primary position (straight ahead) in 73% 
of individuals with IN.8 If the null zone is not in the primary 
position, patients may adopt an abnormal head posture (AHP) 
to place the eyes in this position. In many individuals (44%), 
nystagmus intensity also reduces during convergence.8,12,13 
Furthermore, the state of attention and fatigue can affect 
nystagmus intensity.14 Stress, for example, has been found 
to increase intensity.15,16 These factors should be taken into 
consideration during an eye examination, as they may affect 
the outcome of clinical tests.
A total of 12 waveform patterns have been identified in 
IN.4 These 12 waveforms can be broadly categorized into 
pendular and jerk waveforms (Figure 2). The velocity of 
a pendular eye movement is equal in both directions. The 
eyes may change direction smoothly, producing a sinusoidal 
pendular waveform, or they may change direction abruptly, 
producing a triangular waveform.17 Jerk waveforms, however, 
consist of a slow phase in one direction followed by a cor-
rective saccade, known as a fast phase. It is further described 
by the direction of the fast phase, whether it is left, right, up, 
or down. A specific characteristic of the jerk IN waveform 
that distinguishes it from other types of nystagmus is the 
accelerating slow phase that follows the foveation period; a 
period when the eye movement is relatively slower for a short 
period of time when the object of regard coincides with the 
fovea.17,18 An accelerating slow phase is unlikely to be vis-
ible to an examiner, so this can only be confirmed by using 
a high-speed eye tracking device.
The evolution of the IN waveform during visual develop-
ment has been investigated by a number of researchers. One of 
the earliest studies – in three infants – reported that IN started 
with large triangular waveforms, developing into pendular 
Figure 1 Waveform showing the initiation (slow) phase and correction (fast) phase 
of a jerk nystagmus cycle.
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Figure 2 (A) Pendular and (B) jerk waveform patterns in IN.
Abbreviation: IN, infantile nystagmus.
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and, subsequently, jerk waveform nystagmus by 7 months 
to 1.5 years.1 However, a later study observed square-wave 
jerks (a form of saccadic intrusion) at 7 weeks of age, which 
then developed into a smaller amplitude (4°–20°) pendular 
nystagmus at 8 weeks.20 Over the next few weeks, the ampli-
tude first increased (to approximately 30°) and then began to 
decrease to 4°–10° until 7.5 months. A more recent study was 
conducted on a group of 20 infants aged between 4 and 42 
months in whose nystagmus a combination of two components 
was observed, ie, asymmetric pendular and pseudocycloid 
waveforms, which was previously undocumented.21 In addi-
tion, the researchers observed a decrease in the amplitude of 
both components of waveforms from birth until 1.5 years of 
age. Foveation duration also increased up to the age of 1.5–2 
years, and thereafter remained relatively stable.
Although the exact type of IN waveform is not crucial 
for the diagnosis of IN itself, knowledge about the different 
waveforms is helpful in estimating the visual prognosis. 
For instance, pendular waveforms are more likely to be 
associated with an identifiable visual system pathology.22 
Therefore, children with a pendular waveform that persists 
longer are suspected to have more poorly developed vision, 
as compared to children who transition to a jerk waveform 
earlier.23 Although access to eye movement recording equip-
ment is limited in optometric practices, it is usually possible 
to determine whether a waveform is pendular or jerk without 
an eye tracker, just by direct observation. Jerk nystagmus, 
for instance, can be determined simply by observing the beat 
direction (ie, fast phase).
Visual acuity (VA)
VA varies widely in patients with IN, depending on the asso-
ciated visual condition (if any). The mean VA of individuals 
with idiopathic IN (IN with no associated visual pathology) 
is 0.35 logMAR, which is better than that of individuals 
with associated visual system pathology (0.67 logMAR in 
patients with albinism, and 0.55 logMAR in the group with 
any other ocular pathology).8 The poor VA seen in patients 
with IN could be due to the underlying pathology, motion-
blur-induced stimulus deprivation amblyopia, or a combina-
tion of both.24
Refractive error
Individuals with IN are more likely to have high refractive 
error than the general population. The range of refractive 
errors found in patients with IN is very broad. Some studies 
find that hyperopia is more common in IN,25 regardless of 
the VA,26 while others report that the trend is more myopic.27 
The prevalence of corneal astigmatism (especially with-the-
rule astigmatism) is also remarkably high in individuals with 
IN.28 The average amount of astigmatism in these individuals 
is 1.85DC; 57% of people with IN have astigmatism higher 
than 2.00DC.8 Astigmatism tends to increase with age29 and 
is suspected to be caused by the interaction between the 
cornea and the eyelids during the constant oscillations.28,30 
Although full correction is given, patients with IN are better 
able to distinguish horizontal stimuli than vertical ones,24,31–33 
which may be attributable to the presence of meridional 
amblyopia.33,34
Reading performance
Nystagmus intensity decreases when converging to view near 
objects in around 44% of individuals with IN.8,12 However, 
there is no significant improvement in near VA at this time, 
despite significant dampening of the nystagmus.11,9 Barot 
et al35 studied the reading performance of 71 individuals 
with IN and 20 controls, measuring reading acuity, near VA, 
and reading speed. Reading performance was 18.8% slower 
in participants with IN associated with albinism and 14.7% 
slower in idiopaths. However, near-normal reading speed 
can be accomplished by using a font size up to 0.6 logMAR 
larger than the near VA.35
Reversed optokinetic nystagmus (OKN) 
response
Another unique characteristic of IN is reversal of the OKN 
response. In a typical person without nystagmus, the fast 
phase of OKN beats in the opposite direction to the stimulus. 
However, some individuals with IN show a reversed response, 
ie, the fast phase of the OKN beats in the same direction as 
the stimulus.36,22
Oscillopsia
Despite the constant oscillation of the eyes that produce reti-
nal image motion, people with nystagmus generally perceive 
the world as stable.37 Therefore, they rarely complain of oscil-
lopsia38 (perception of the world swinging back and forth).39 
In contrast, oscillopsia is commonly experienced by patients 
with acquired nystagmus.22 However, reports of oscillopsia 
are not necessarily indicative of acquired nystagmus, but 
should be an indication for further investigation. Individuals 
with IN can sometimes experience oscillopsia intermittently 
in situations such as when they are tired, excited, stressed, 
or concentrating.8
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Head nodding
Another occasional feature of IN is head nodding.8 This head 
oscillation is independent of the oscillation occurring in the 
eyes, often being in a different direction or with a different 
phase. Head nodding clearly does not compensate for the 
nystagmus eye movements, and its etiology is unclear. It can 
be suppressed by the patient voluntarily, but may recur if the 
patient’s attention is distracted from doing so.40 This feature 
of IN is also present in SNS, but in SNS, the head oscillation 
is in synchrony with the eyes. Key distinguishing features 
of SNS and IN can be seen in eye movement recordings, as 
the waveform of SNS is asymmetrical between the two eyes, 
pendular, high in frequency, and low in amplitude.2,22
Associated conditions vs idiopathic IN
IN can present with anterior visual pathway abnormalities, or 
it can present without any detectable abnormalities at all (ie, 
it can be idiopathic). Anterior visual pathway abnormalities 
occur in 38%–91% of cases of IN.3,8,41,42 This includes, but is 
not limited to, congenital cataracts, retinal dystrophies, and 
degenerations such as Leber’s congenital amaurosis, optic 
nerve disorders such as optic nerve hypoplasia and optic 
atrophy, foveal hypoplasia, aniridia, albinism, achromatop-
sia, and achiasma. Only 9% of cases of IN are reported as 
idiopathic,41,42 although Lorenz and Gampi43 and Abadi and 
Bjerre8 reported a higher prevalence. However, since the 
idiopathic diagnosis can only be reached after all possible 
associated visual conditions have been excluded, the preva-
lence of IN depends to some extent upon the persistence of 
the investigator and the exhaustiveness of clinical testing. 
Children with IN associated with sensory abnormalities tend 
to have poorer vision than those who are idiopathic. There-
fore, it is important to distinguish the two so that appropriate 
management can be given.
Optometric investigation of IN
Although unlikely, an optometrist may come across a patient 
with nystagmus (whether a child or an adult) who has not been 
seen by the hospital eye services. Referral of these cases is 
essential so that an underlying cause can be identified, if pos-
sible. The optometrist must ascertain the appropriate speed 
of referral by deciding, following a detailed discussion of 
history and symptoms, whether the nystagmus is likely to be 
infantile or acquired – the latter requiring emergency refer-
ral. Often, the history can be very informative in making this 
determination. The difficulty in making such a differential 
diagnosis by signs is due to the fact that the features of IN 
overlap largely with those of acquired nystagmus, FMNS, 
and SNS. However, some key features are distinguishable. 
For example, features of acquired nystagmus include a pro-
nounced vertical component, complaints of oscillopsia, and 
saccadic oscillations without apparent slow phases (techni-
cally, saccadic oscillations are not a form of nystagmus, but 
these conditions are often misdiagnosed as such and require 
onward referral).22 Note that asymmetrical movements 
between the two eyes raises the likelihood of the nystagmus 
being acquired, although this feature may not be seen with 
the naked eye. IN is not a progressive condition, and changes 
in nystagmus are not expected in adulthood. Therefore, any 
suspected changes in nystagmus in adults should always be 
referred to the hospital eye service  as they could represent 
(however unlikely) the development of comorbid acquired 
nystagmus.
On the other hand, FMNS is often associated with infan-
tile esotropia and amblyopia (which disrupts binocularity).44 
In FMNS, nystagmus might not be observable under binocu-
lar viewing (without eye movement recording) but becomes 
apparent when one eye is occluded. The nystagmus fast phase 
will be seen beating toward the uncovered eye, while remain-
ing conjugate. FMNS respects Alexander’s Law, ie, that the 
nystagmus gets more intense in abduction. This means that 
if the left eye is viewing, the nystagmus is more intense in 
leftgaze, and vice versa. Moreover, in IN, an increase in the 
intensity can sometimes be seen when one eye is covered, 
indicating the presence of a latent component. Therefore, the 
cover test should be performed to determine the presence of 
a latent component or FMNS.
Key features of SNS include a low amplitude, high 
frequency (often >10 Hz), and asymmetrical pendular 
nystagmus that may be conjugate or disconjugate. In addi-
tion, children with SNS usually present with AHP and head 
nodding.2,22 Also, oscillations of the eyes often reduce to 
subclinical levels after a few years,45,46 giving the impression 
that the nystagmus has disappeared.
Performing tests on patients with nystagmus can be 
a clinical challenge requiring good skills. For example, 
tests that require the eyes to be still – such as noncontact 
 tonometry – may be difficult to undertake. However, the 
alternative of using a contact tonometer has a higher risk 
of causing corneal abrasion. The clinician will need to use 
their individual judgment in each situation depending on the 
patient and test being performed. Consider using the patient’s 
null zone to dampen nystagmus while carrying out tests 
such as perimetry. As mentioned earlier, stress can increase 
nystagmus intensity, so the practitioner should do everything 
possible to minimize the patient’s anxiety and discomfort.
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Nystagmus intensity increases with occlusion in patients 
with a latent component, which may produce an artefactual 
reduction in VA. To avoid this increase in intensity, fogging 
should be used to remove fixation of the untested eye, using 
convex lenses between +4.00DS and +10.00DS.47 Studies 
have shown that patients with IN take longer to direct their 
gaze toward a fixated target and report slowness to see.48,49 
Therefore, giving patients more time to respond when read-
ing the acuity chart would be beneficial to both the patient 
and practitioner.
Although performing refraction on a patient with nys-
tagmus may seem challenging, an accurate refraction can 
still be obtained. The use of trial frames and wide-aperture 
trial lenses (as opposed to a phoropter) are advantageous, as 
they allow the patient to move their head freely toward – if 
not into – their null zone.
Slit-lamp examination and funduscopy are essential 
to rule out conditions commonly associated with IN. The 
practitioner should look for structural abnormalities such as 
iris transillumination (albinism) and congenital cataracts. 
During funduscopy, attention should be paid to abnormali-
ties in the optic disc (optic nerve hypoplasia), fovea (foveal 
hypoplasia in albinism or aniridia), and fundus pigmentation. 
Optical coherence tomography should be used to assess for 
foveal hypoplasia. Given that idiopathic IN is a diagnosis by 
exclusion, the hospital eye service can be expected to perform 
electroretinography  and visual evoked potentials  to assess 
for disorders such as congenital stationary night-blindness 
and cone dysfunction, which can be difficult to detect with 
funduscopy alone.
Management by the optometrist
In this paper, we focus on the approaches that involve 
optometrists in the management of individuals with IN. This 
includes the prescription of optical treatments, low-vision 
rehabilitation, and other interventions such as use of the null 
zone and support groups.
Optical prescription
As might be expected, correction of refractive error has been 
shown to improve the VA of individuals with IN.50,51 Correc-
tion of even the smallest significant amount of refractive error 
can result in subjective improvements in vision. Therefore, 
the management should begin with correction of refractive 
errors, usually with spectacles. However, the use of spec-
tacles may not be ideal in patients with an AHP caused by an 
eccentric null zone, as it may require them to use an eccentric 
point of the lens. This will induce prismatic and peripheral 
lens effect aberrations, leading to blurred vision and perhaps 
asthenopia. In such cases, contact lenses may be prescribed.
The use of contact lenses to correct refractive error has 
been reported to improve VA by at least one line when com-
pared to the use of spectacles.52,53 The presence of contact 
lenses on the eyes appears to dampen nystagmus intensity, 
an effect that does not occur when the eye is anesthetized.54 
This suggests that correction of refractive error may not 
be the primary mechanism involved, and that the sensory 
feedback from the contact lenses on the cornea or lids might 
have a moderating impact on the nystagmus. The presence 
of high with-the-rule astigmatism in patients with IN leads 
to a higher sensitivity to rotational instability of the contact 
lens, resulting in reduced VA.55 Therefore, special care must 
be taken when fitting contact lenses to these patients. The use 
of rigid gas-permeable lenses may provide a more stable fit 
compared to soft lenses in these cases.55
Prisms may be used to reduce AHP by shifting the eyes 
into the null position while the head is in the primary posi-
tion. As an example, base right prisms can be used to shift 
the eyes into left gaze for patients with a leftward null zone, 
allowing the head to remain straight (Figure 3). Be aware that 
eccentric null positions will require high powered prisms, 
which may be heavy. An alternative is to use Fresnel stick-
on prisms, although neither option may be cosmetically 
acceptable to the patient. Patients with IN who have a null 
zone in the convergent position may benefit from wearing 
base out spectacle prisms that will induce convergence and 
thus dampen nystagmus intensity when viewing distant 
targets.56 This can be achieved by prescribing 7Δ base out 
in front of both eyes, with –1.00DS to compensate for the 
Figure 3 Example of reducing a right AHP (A) using base right prisms to shift 
the eyes into the direction of the null zone (left gaze) while the head is in primary 
position (B).
Abbreviation: AHP, abnormal head posture.
BA
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 accommodation that accompanies the convergence.57,40 In rare 
cases, some nystagmats may present with a divergence null. 
In such cases, base-in prisms would be beneficial.58
Low-vision rehabilitation
As discussed above, the VA of individuals with IN is usually 
reduced. Although some may have 6/6 or better vision, most 
are visually impaired, affecting their ability to perform daily 
tasks. For this group of individuals, low-vision rehabilitation 
is beneficial. This includes increasing the font size of texts 
together with the use of optical or electronic magnification 
devices. The use of devices such as tablets is ideal, as these 
can provide a wide range of magnifications. Additionally, 
other adaptive strategies during viewing (eg, use of the null 
zone) can also be trained.
Use of the null zone
Many of the interventions available for IN aim to utilize the 
null zone, which has been shown to improve VA.59 Nystagmats 
sometimes adopt an AHP to achieve the required gaze position, 
but long-term use of such head postures may lead to a restric-
tion of neck movement.60 Besides using prisms, adjustment to 
the surroundings, such as changing the seating position during 
viewing, can be made to place the eyes into the null zone while 
keeping the head straight. Such adjustments may improve 
the patient’s comfort for long periods of viewing. Figure 4 
illustrates an example of environmental changes that can be 
made in a classroom for a child with a null zone in left gaze.
Support groups
IN is a lifelong condition that affects not only visual function 
but also the quality of life of patients and those who are close 
to them.61,62 A recent study by McLean et al61 investigated the 
impact of nystagmus on the daily life of patients older than 
16 years. The authors found that the physical appearance of 
nystagmus causes individuals to suffer from low self-esteem. 
The constant oscillation of the eyes and AHP made partici-
pants feel that they stand out and/or do not fit in with their 
peers. This can lead to social withdrawal. An earlier study by 
Pilling et al62 on the social and visual function in nystagmus 
discovered that children with nystagmus have poorer social 
function compared to adults.
Besides confidence issues, many individuals with nystag-
mus feel frustrated with the lack of understanding from the 
general public regarding their condition. Many also report 
feeling abandoned by the medical community. This can lead 
to feelings of hopelessness and fear of failing.61 The findings 
from these studies demonstrate the importance of raising 
awareness of nystagmus and the need for support groups for 
patients. Therefore, it is important for patients to get the cor-
rect information and support regarding their condition. In the 
UK, patients with any form of nystagmus can be referred to 
Nystagmus Network (http://nystagmusnetwork.org), a char-
ity and support group that provides information and support 
for family members and children who are growing up with 
nystagmus.63 Child patients should always be referred to the 
Local Educational Authority’s VI support service.
Treatments for IN
A number of treatments by ophthalmologists are available for 
nystagmus depending on the type and presenting symptoms. 
These treatments do not completely cure the nystagmus, but 
rather modify the waveform and/or reduce AHP. A review by 
Thurtell and Leigh64 discusses the various therapies available 
for different types of nystagmus, including both surgical 
and pharmaceutical options. As with optical treatments, the 
aims are to improve the VA, correct any AHP, and treat any 
strabismus.47 Some treatments also aim to reduce nystagmus 
intensity.47,64
Surgical treatment
Several surgical procedures have been reported to improve 
nystagmus in patients with IN. Surgery is indicated when 
there is a null point at eccentric gaze causing a significant 
AHP, presence of strabismus, or to improve VA through 
the use of convergence.65,66 One of the earliest surgical pro-
cedures to be developed involved recession and resection 
of the extraocular muscles to move the null zone into the 
primary position of gaze (Kestenbaum surgery).67 Artificial 
divergence surgery is another method involving recession 
Figure 4 Example of environmental changes for a child with a left null zone (A). The 
child can be seated to on the right side of the classroom/television to place the eyes 
into the left gaze for a more comfortable head posture (B).
Abbreviation: AHP, abnormal head posture.
A B
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of both medial rectus muscles in patients with nystagmus 
that dampens on convergence.68 A combination of this 
surgery with the Kestenbaum technique has been shown to 
produce a better visual outcome compared to performing 
each procedure on its own.69,70 Following the success of the 
Kestenbaum surgery in improving VA in patients with IN, it 
was hypothesized that similar outcomes would be produced 
through a combined procedure of tenotomy (detachment of 
the muscles) and reattachment at the same site of the muscle 
origin.71 Subjective improvement in VA has been reported. 
However, there are only limited reports of improvement in 
clinically measured VA.71–74
Pharmacological treatment
Various drugs have been reported to reduce nystagmus 
intensity in IN.75 The only ones to have gone through a 
randomized controlled trial are memantine and gabapentin. 
The improvement in vision seen with the prescription of 
memantine was 0.15 logMAR compared to placebo (0.04 
logMAR). Slightly less improvement in VA was seen with 
gabapentin (0.09 logMAR).75–77
Cannabis and baclofen have also shown potential for 
improving VA in IN, but these medications have not under-
gone rigorous testing. The effect of smoking cannabis was 
shown through eye movement recordings and improved VA 
in one case study of a 19-year-old patient with nystagmus.78 
Baclofen is known to reduce nystagmus amplitude and AHP 
and increase VA, and is often used in patients with periodic 
alternating nystagmus, a form of IN that reverses direction.79 
The reader is directed to recent review articles for a full 
discussion of other pharmacological treatments of IN.80–82
Conclusion
The principal aim of an optometrist’s investigation of a patient 
with nystagmus should be to distinguish the characteristics 
that differentiate IN from the various other forms of the con-
dition. This can be difficult, as many of the features overlap 
in the various subtypes. Correct diagnosis is crucial however, 
as proper management may at the least improve quality of 
life, and a referral might even save a life. Management of 
IN does not involve a cure, but rather minimization of the 
intensity, thereby improving the physical appearance, and 
potentially improving visual function. Management of IN 
depends on understanding and treating the associated visual 
system pathology (if any) and maximizing use of the null 
zone. Small changes in clinical measurements may impact 
the patient’s visual function significantly. Therefore, it is 
advantageous for optometrists to have adequate knowledge 
of the therapies available.
The potential impact of this lifelong condition on the 
visual function and psychological well-being of those who 
have it warrants a thorough clinical examination and man-
agement. It is well worth providing the patient with a good 
understanding of their own condition through additional care 
and attention.
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